GENinCode (LON:GENI – Get Free Report) announced its quarterly earnings data on Monday. The company reported GBX (2.08) EPS for the quarter, Digital Look Earnings reports. The firm had revenue of GBX 308 million during the quarter. GENinCode had a negative return on equity of 262.16% and a negative net margin of 170.49%.
GENinCode Price Performance
Shares of GENI opened at GBX 1 on Tuesday. The stock has a market capitalization of £7.25 million, a P/E ratio of -0.43 and a beta of 0.59. GENinCode has a twelve month low of GBX 0.90 and a twelve month high of GBX 5.50. The company has a 50 day moving average of GBX 1.13 and a 200-day moving average of GBX 1.54. The company has a quick ratio of 15.89, a current ratio of 2.80 and a debt-to-equity ratio of 7.17.
About GENinCode
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.
See Also
- Five stocks we like better than GENinCode
- Campbell’s Soup Stock: Deep Value and a 7% Dividend Yield
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
